Predicting the primary infection source of Escherichia coli bacteremia using virulence-associated genes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 694 KB, PDF-dokument

Purpose
To investigate the role of E. coli virulence-associated genes (VAGs) in predicting urinary tract infection (UTI) as the source of bacteremia in two distinct hospital populations, one with a large general catchment area and one dominated by referrals.

Methods
E. coli bacteremias identified at Department of Clinical Microbiology (DCM), Hvidovre Hospital and DCM, Rigshospitalet in the Capital Region of Denmark from October to December 2018. Using whole genome sequencing (WGS), we identified 358 VAGs from 224 E. coli bacteremia. For predictive analysis, VAGs were paired with clinical source of UTI from local bacteremia databases.

Results
VAGs strongly predicting of UTI as primary infection source of bacteremia were primarily found within the pap gene family. papX (PPV 96%, sensitivity 54%) and papGII (PPV 93%, sensitivity 56%) were found highly predictive, but showed low sensitivities. The strength of VAG predictions of UTI as source varied significantly between the two hospital populations. VAGs had weaker predictions in the tertiary referral center (Rigshospitalet), a disparity likely stemming from differences in patient population and department specialization.

Conclusion
WGS data was used to predict the primary source of E. coli bacteremia and is an attempt on a new and different type of infection source identification. Genomic data showed potential to be utilized to predict the primary source of infection; however, discrepancy between the best performing profile of VAGs between acute care hospitals and tertiary hospitals makes it difficult to implement in clinical practice.
OriginalsprogEngelsk
TidsskriftEuropean Journal of Clinical Microbiology and Infectious Diseases
Vol/bind43
Udgave nummer4
Sider (fra-til)641-648
Antal sider8
ISSN0934-9723
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
Open access funding provided by Copenhagen University. Authors H.K.J., H.W., and J.M. were supported by a grant from The Novo Nordisk Foundation (Ref. nr.: NNF18SA0035306)—Pasteur21 POC. Author H.K.J. was supported by a Challenge grant (Ref. nr.: NNF19OC0056411), and authors H.K.J. and H.W. were supported by a Clinical-Academic-Group (CAG)—Greater Copenhagen Health—Science—Partners, 2020. BACINFECT.

Publisher Copyright:
© 2024, The Author(s).

ID: 381785114